BK virus in transplant recipients: current perspectives

References

• Gardner S, Field A, Coleman D, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1(7712):1253–1257. doi:10.1016/s0140-6736(71)91776-4
   PubMed Web of Science ®Google Scholar
• Calvignac-Spencer S, Feltkamp MCW, Daugherty MD, et al. A taxonomy update for the family polyomaviridae. Arch Virol. 2016;161(6):1739–1750. doi:10.1007/s00705-016-2794-y
   Web of Science ®Google Scholar
• Imperiale M, Major E. Polyomaviruses. In: Fields Virology. 5th ed. Philadelphia: Lippincott Williams&WIlkins; 2007:2263–2298.
   Google Scholar
• Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71(1):115–123. doi:10.1002/jmv.10450
   PubMed Web of Science ®Google Scholar
• Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199(6):837–846. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19434930.
   Google Scholar
• Polo C, Pérez JL, Mielnichuck A, Fedele CG, Niubó J, Tenorio A. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect. 2004;10(7):640–644. doi:10.1111/j.1469-0691.2004.00882.x
   Web of Science ®Google Scholar
• Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009;5(3):e1000363. doi:10.1371/journal.ppat.1000706
   PubMed Web of Science ®Google Scholar
• Hirsch H, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. N Engl J Med. 2002;347(7):488–496. doi:10.1056/NEJMoa020439
   PubMed Web of Science ®Google Scholar
• Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323–330. doi:10.1097/01.tp.0000269706.59977.a5
   PubMed Web of Science ®Google Scholar
• Zhong S, Randhawa PS, Ikegaya H, et al. Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol. 2009;90(1):144–152. doi:10.1099/vir.0.83611-0
   Google Scholar
• Ikegaya H, Saukko PJ, Tertti R, et al. Identification of a genomic subgroup of BK polyomavirus spread in European populations. J Gen Virol. 2006;87(11):3201–3208. doi:10.1099/vir.0.82266-0
   Google Scholar
• Vanchiere JA, Nicome RK, Greer JM, Demmler GJ, Butel JS. Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis. 2005;192(4):658–664. doi:10.1086/432076
   Web of Science ®Google Scholar
• Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol. 2009;47(8):2388–2391. doi:10.1128/JCM.02472-08
   Web of Science ®Google Scholar
• Wong ASY, Cheng VCC, Yuen KY, Kwong YL, Leung AYH. High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant. 2009;43(1):43–47. doi:10.1038/bmt.2008.266
   Web of Science ®Google Scholar
• Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. J Virol. 2000;66(1):238–245.
   Google Scholar
• Bofill-mas L, Formiga-cruz M, Clemente-casares P, Calafell F, Girones R. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA edited by Foxit reader. J Virol. 2008;2(C):10290–10299.
   Google Scholar
• Goudsmit J, Dillen PW, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol. 1982;10(2):91–99.
   PubMed Web of Science ®Google Scholar
• Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 2019;147(4):676–684. doi:10.1093/infdis/147.4.676
   Google Scholar
• Thangaraju S, Gill J, Wright A, Dong J, Rose C, Gill J. Risk factors for BK polyoma virus treatment and association of treatment with kidney transplant failure: insights from a paired kidney analysis. Transplantation. 2016;100(4):854–861. doi:10.1097/TP.0000000000000890
   Web of Science ®Google Scholar
• Schold JD, Rehman S, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009;22(6):626–634. doi:10.1111/j.1432-2277.2009.00842.x
   Web of Science ®Google Scholar
• Masutani K, Ninomiya T, Randhawa P. HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia. Nephrol Dial Transplant. 2013;28(12):3119–3126. doi:10.1093/ndt/gft298
   Web of Science ®Google Scholar
• Sharif A, Alachkar N, Bagnasco S, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(8):1320–1327. doi:10.2215/CJN.00770112
   Web of Science ®Google Scholar
• Bentall A, Neil D, Sharif A, Ball S. ABO-incompatible kidney transplantation is a novel risk factor for BK nephropathy. Transplantation. 2015;99(2):e8–e9. doi:10.1097/TP.0000000000000483
   Web of Science ®Google Scholar
• DeWolfe D, Gandhi J, Mackenzie MR, et al. Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients. PLoS One. 2017;12(5):1–15. doi:10.1371/journal.pone.0177339
   Web of Science ®Google Scholar
• Schaenman JM, Korin Y, Sidwell T, et al. Increased frequency of BK virus-specific polyfunctional CD8+ T cells predict successful control of BK viremia after kidney transplantation. Transplantation. 2017;101(6):1479–1487. doi:10.1097/TP.0000000000001314
   Web of Science ®Google Scholar
• Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant. 2005;5(9):2213–2221. doi:10.1111/j.1600-6143.2005.01000.x
   Web of Science ®Google Scholar
• Schmitt C, Raggub L, Linnenweber-Held S, Adams O, Schwarz A, Heim A. Donor origin of BKV replication after kidney transplantation. J Clin Virol. 2014;59(2):120–125. doi:10.1016/j.jcv.2013.11.009
   Web of Science ®Google Scholar
• Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C. Viral origin, clinical course, and renal outcomes in patients with BK virus infection after living-donor renal transplantation. Transplantation. 2016;100(4):844–853. doi:10.1097/TP.0000000000001066
   Web of Science ®Google Scholar
• Wunderink HF, De Brouwer CS, Gard L, et al. Source and relevance of the BK polyomavirus genotype for infection after kidney transplantation. Pen Forum Infect Dis. 2019;6(3):1–6. doi:10.1093/ofid/ofz078
   Web of Science ®Google Scholar
• Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003;3(10):611–623.
   PubMed Web of Science ®Google Scholar
• Pahari A, Rees L. BK virus-associated renal problems - clinical implications. Pediatr Nephrol. 2003;18(8):743–748. doi:10.1007/s00467-003-1184-3
   Web of Science ®Google Scholar
• Coleman DV, Mackenzie EFD, Gardner SD, Poulding JM, Amer B, Russell WJ. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol. 1978;31(4):338–347. doi:10.1136/jcp.31.4.338
   Web of Science ®Google Scholar
• van Gorder MA, Della Pelle P, Henson JW, Sachs DH, Cosimi AB, Colvin RB. Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys. Am J Pathol. 2011;154(4):1273–1284. doi:10.1016/S0002-9440(10)65379-5
   Google Scholar
• Muñoz P, Fogeda M, Bouza E, Verde E, Palomo J, Bañares R. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis. 2005;41(12):1720–1725. doi:10.1086/498118
   Web of Science ®Google Scholar
• Razonable R, Brown R, Humar A, Covington E, Alecock E, Paya C. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis. 2019;192(8):1349–1354. doi:10.1086/466532
   Google Scholar
• Loeches B, Valerio M, Peréz M, et al. BK virus in liver transplant recipients: a prospective study. Transplant Proc. 2009;41(3):1033–1037. doi:10.1016/j.transproceed.2009.02.021
   Web of Science ®Google Scholar
• Dropulic L, Jones R. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008;41(1):58. doi:10.1038/sj.bmt.1705886
   Web of Science ®Google Scholar
• Group KDIGO (KDIGO) TW. Special issue: KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9:S1–S155. doi:10.1111/j.1600-6143.2009.02834.x
   Google Scholar
• Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277–1286. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15912088.
   Google Scholar
• Tan SK, Milligan S, Sahoo MK, Taylor N, Pinsky BA. Calibration of BK virus nucleic acid amplification testing to the 1st WHO international standard for BK virus. J Clin Microbiol. 2017;55(3):923–930. doi:10.1128/JCM.02315-16
   Web of Science ®Google Scholar
• Randhawa P, Finkelstein S, Scantelbury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67(1):103–109. doi:10.1097/00007890-199901150-00018
   PubMed Web of Science ®Google Scholar
• Drachenberg C, Beskow C, Cangro CB, et al. Human polyoma virus in renal allograft biopsies : morphological findings and correlation with urine cytology. Hum Pathol. 1999;30(8):970–977. doi:10.1016/s0046-8177(99)90252-6
   PubMed Web of Science ®Google Scholar
• Nickeleit V, Singh HK, Randhawa P, et al. The banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol. 2017;29(2):680–693. doi:10.1681/ASN.2017050477
   Web of Science ®Google Scholar
• Brennan D, Bromberg J, Yee J, Dholakia S, Haas M. Donor derived cell free DNA (dd-cfDNA) May aid in the diagnosis of BK virus nephropathy [abstract]. Am J Transplant. 2019;19(suppl 3). Available from: https://atcmeetingabstracts.com/abstract/donor-derived-cell-free-dna-dd-cfdna-may-aid-in-the-diagnosis-of-bk-virus-nephropathy.
   Google Scholar
• Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation. 2010;89(9):1057–1070. doi:10.1097/TP.0b013e3181d0e15e
   Web of Science ®Google Scholar
• Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation. 2008;85(6):850–854. doi:10.1097/TP.0b013e318166cba8
   PubMed Web of Science ®Google Scholar
• Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582–594. doi:10.1111/j.1600-6143.2005.00742.x
   Web of Science ®Google Scholar
• Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant. 2010;10(2):407–415. doi:10.1111/j.1600-6143.2009.02952.x
   Web of Science ®Google Scholar
• Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant. 2010;10(12):2615–2623. doi:10.1111/j.1600-6143.2010.03310.x
   Web of Science ®Google Scholar
• Schaub S, Steiger J, Hirt-Minkowski P, et al. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes. Nephrol Dial Transplant. 2018:1–11. doi:10.1093/ndt/gfy346
   Google Scholar
• Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation. 2012;94(8):814–821. doi:10.1097/TP.0b013e31826690c6
   Web of Science ®Google Scholar
• Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation. 2006;81(1):117–120. doi:10.1097/01.tp.0000181096.14257.c2
   Web of Science ®Google Scholar
• Randhawa P, Pastrana DV, Zeng G, et al. Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK. Am J Transplant. 2015;15(4):1014–1020. doi:10.1111/ajt.13083
   PubMed Web of Science ®Google Scholar
• Shah T, Vu D, Naraghi R, Campbell A, Min D. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients. Clin Transpl. 2014;109–116.
   Google Scholar
• Sharma AP, Moussa M, Casier S, Rehman F, Filler G, Grimmer J. Intravenous immunoglobulin as rescue therapy for BK virus nephropathy. Pediatr Transplant. 2009;13(1):123–129. doi:10.1111/j.1399-3046.2008.00958.x
   Web of Science ®Google Scholar
• Nankivell BJ, Davies CD, Kable K, Oʼconnell PJ, Chapman JR. Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin. Transplant Direct. 2017;3(4):e142. doi:10.1097/txd.0000000000000641
   Google Scholar
• Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006;81(5):704–710. doi:10.1097/01.tp.0000181149.76113.50
   PubMed Web of Science ®Google Scholar
• Liacini A, Seamone ME, Muruve DA, Tibbles LA. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation. 2010;90(12):1450–1457. doi:10.1097/TP.0b013e3182007be2
   Web of Science ®Google Scholar
• Krisl JC, Taber DJ, Pilch N, et al. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012;7(6):1003–1009. doi:10.2215/CJN.12531211
   Web of Science ®Google Scholar
• Guasch A, Roy-Chaudhury P, Woodle ES, Fitzsimmons W, Holman J, First MR. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation. 2010;90(8):891–897. doi:10.1097/TP.0b013e3181f2c94b
   Web of Science ®Google Scholar
• Ali SH, Chandraker A, DeCaprio JA. Inhibition of simian virus 40 large T antigen helicase activity by fluoroquinolones. Antivir Ther. 2007;12(1):1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17503741.
   Google Scholar
• Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010;5(7):1298–1304. doi:10.2215/CJN.08261109
   PubMed Web of Science ®Google Scholar
• Wojciechowski D, Chanda R, Chandran S, et al. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012;94(11):1117–1123. doi:10.1097/TP.0b013e31826ec74e
   PubMed Web of Science ®Google Scholar
• Lee BT, Gabardi S, Grafals M, et al. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol. 2014;9(3):583–589. doi:10.2215/CJN.04230413
   Web of Science ®Google Scholar
• Acott PD, O’Regan PA, Lee SH, Crocker JFS. In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells. Transpl Infect Dis. 2008;10(6):385–390. doi:10.1111/j.1399-3062.2008.00330.x
   Web of Science ®Google Scholar
• Li Y-J, Weng C-H, Lai W-C, et al. A suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus. Transplantation. 2010;89(3):299–306. doi:10.1097/tp.0b013e3181c9b51c
   Web of Science ®Google Scholar
• Wali RK, Drachenberg C, Hirsch HH, et al. BK virus-associated nephropathy in renal alloqraft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation. 2004;78(7):1069–1073. doi:10.1097/01.TP.0000142127.84497.50
   Web of Science ®Google Scholar
• Hirsch HH, Yakhontova K, Lu M, Manzetti J. BK polyomavirus replication in renal tubular epithelial cells is inhibited by sirolimus, but activated by tacrolimus through a pathway involving FKBP-12. Am J Transplant. 2016;16(3):821–832. doi:10.1111/ajt.13541
   Web of Science ®Google Scholar
• Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F. Mycophenolate mofetil withdrawal with conversion to everolimus to treat BK virus infection in kidney transplant recipients. Transplant Proc. 2017;49(8):1773–1778. doi:10.1016/j.transproceed.2017.06.030
   PubMed Web of Science ®Google Scholar
• Mallat SG, Tanios BY, Itani HS, et al. CMV and BKPyV infections in renal transplant recipients receiving an mtor inhibitor–based regimen versus a cni-based regimen: a systematic review and meta-analysis of randomized, controlled trials. Clin J Am Soc Nephrol. 2017;12(8):1321–1336. doi:10.2215/CJN.13221216
   PubMed Web of Science ®Google Scholar
• Pello OM, Innes AJ, Bradshaw A, et al. BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation. Eur J Haematol. 2017;98(6):632–634. doi:10.1111/ejh.12848
   Web of Science ®Google Scholar
• Papadopoulou A, Gerdemann U, Katari UL, et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT. Sci Transl Med. 2014;6(242):1–12. doi:10.1126/scitranslmed.3008825
   Web of Science ®Google Scholar